| Non-canonical inflammasome activation mediates the adjuvanticity of nanoparticles N Muñoz-Wolf, RW Ward, CH Hearnden, FA Sharp, J Geoghegan, ... Cell Reports Medicine 4 (1), 100899, 2023 | 12 | 2023 |
| Myeloid cell–derived proteases produce a proinflammatory form of IL-37 that signals via IL-36 receptor engagement GP Sullivan, P Davidovich, N Muñoz-Wolf, RW Ward, ... Science Immunology 7 (78), eade5728, 2022 | 5 | 2022 |
| Enhancing antigen cross-presentation and CD8 (+) T cell responses by adsorbing antigen to nanoparticles J Huete-Carrasco, N Munoz-Wolf, RW Ward, EC Lavelle EUROPEAN JOURNAL OF IMMUNOLOGY 52, 4-4, 2022 | | 2022 |
| Inflammasome activating nanoparticles promote protective anti-tumour CD8 (+) T cells R Ward, N Munoz-Wolf, EC Lavelle EUROPEAN JOURNAL OF IMMUNOLOGY 52, 25-25, 2022 | | 2022 |
| Promotion of trained innate immunity by nanoparticles N Muñoz-Wolf, EC Lavelle Seminars in immunology, 101542, 2021 | 4 | 2021 |
| Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease C Healy, N Munoz-Wolf, J Strydom, L Faherty, NC Williams, S Kenny, ... Respiratory Research 22 (1), 1-44, 2021 | 42 | 2021 |
| Chitin-derived polymer deacetylation regulates mitochondrial reactive oxygen species dependent cGAS-STING and NLRP3 inflammasome activation JL Turley, HBT Moran, CP McEntee, K O’Grady, N Muñoz-Wolf, L Jin, ... Biomaterials, 120961, 2021 | 25 | 2021 |
| UCP3 reciprocally controls CD4+ Th17 and Treg cell differentiation EB O’Connor, N Muñoz-Wolf, G Leon, EC Lavelle, KHG Mills, PT Walsh, ... PloS one 15 (11), e0239713, 2020 | 7 | 2020 |
| Type I IFN signalling is required for cationic adjuvant formulation (CAF) 01-induced cellular immunity and mucosal priming CP McEntee, HBT Moran, N Muñoz-Wolf, AM Liddicoat, EC Carroll, ... Vaccine 38 (3), 635-643, 2020 | 4 | 2020 |
| Mycobacterium tuberculosis Limits Host Glycolysis and IL-1β by Restriction of PFK-M via MicroRNA-21 EE Hackett, H Charles-Messance, SM O’Leary, LE Gleeson, ... Cell Reports 30 (1), 124-136. e4, 2020 | 116 | 2020 |
| Caspase-11-Mediated Cell Death Contributes to the Pathogenesis of Imiquimod-Induced Psoriasis S Kenealy, J Manils, M Raverdeau, N Munoz-Wolf, G Barber, A Liddicoat, ... The Journal of investigative dermatology 139 (11), 2389-2393. e3, 2019 | 9 | 2019 |
| Cell survival and cytokine release after inflammasome activation is regulated by the Toll-IL-1R protein SARM M Carty, J Kearney, KA Shanahan, E Hams, R Sugisawa, D Connolly, ... Immunity 50 (6), 1412-1424. e6, 2019 | 120 | 2019 |
| IL-33 Is a Negative Regulator of Vaccine-Induced Antigen-Specific Cellular Immunity NMWECL Katie O’Grady, Claire C. H. Hearnden, Dulce Bento, Ewa Oleszycka ... The Journal of Immunology, 2019 | 3 | 2019 |
| A Guide to IL‐1 family cytokines in adjuvanticity N Muñoz‐Wolf, EC Lavelle The FEBS journal 285 (13), 2377-2401, 2018 | 50 | 2018 |
| The vaccine adjuvant alum promotes IL‐10 production that suppresses Th1 responses E Oleszycka, S McCluskey, FA Sharp, N Muñoz‐Wolf, E Hams, ... European journal of immunology 48 (4), 705-715, 2018 | 88 | 2018 |
| Hippo interferes with antiviral defences N Munoz-Wolf, EC Lavelle Nature cell biology 19 (4), 267-269, 2017 | 11 | 2017 |
| Flagellin-mediated protection against intestinal Yersinia pseudotuberculosis infection does not require interleukin-22 R Porte, L Van Maele, N Muñoz-Wolf, B Foligné, L Dumoutier, J Tabareau, ... Infection and immunity 85 (2), 2017 | 11 | 2017 |
| The role of inflammasomes in adjuvant-driven humoral and cellular immune responses N Muñoz-Wolf, S McCluskey, EC Lavelle Immunopotentiators in Modern Vaccines, 23-42, 2017 | 9 | 2017 |
| Sublingual flagellin protects against acute pneumococcal pneumonia in a TLR5-dependent and NLRC4-independent fashion N Muñoz-Wolf, A Rial, D Fougeron, J Tabareau, JC Sirard, ... Future Microbiology 11 (9), 1167-1177, 2016 | 10 | 2016 |
| The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons EC Carroll, L Jin, A Mori, N Muñoz-Wolf, E Oleszycka, HBT Moran, ... Immunity 44 (3), 597-608, 2016 | 501 | 2016 |
